Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Maria Vitale.
Connection Strength
0.860
-
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med. 2021 03 31; 19(1):132.
Score: 0.234
-
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? J Transl Med. 2020 12 22; 18(1):489.
Score: 0.230
-
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2).
Score: 0.224
-
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. J Immunother Cancer. 2021 02; 9(2).
Score: 0.058
-
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. J Immunother Cancer. 2021 01; 9(1).
Score: 0.058
-
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. J Immunother Cancer. 2020 10; 8(2).
Score: 0.057